Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.
Saved in:
| Title: | Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial. |
|---|---|
| Authors: | Thallinger, Christiane1,2 (AUTHOR), Lang, Istvan3 (AUTHOR), Kuhar, Cvetka Grasic4 (AUTHOR), Bartsch, Rupert1 (AUTHOR), Singer, Christian F5 (AUTHOR), Petruzelka, Lubos6 (AUTHOR), Melichar, Bohuslav7 (AUTHOR), Knittelfelder, Regina2 (AUTHOR), Brodowicz, Thomas1,2 (AUTHOR), Zielinski, Christoph1,2 (AUTHOR) |
| Source: | BMC Cancer. 2/18/2016, Vol. 16, p121-121. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
